There were 356 responses to the 2009 Food Processing R&D survey. The most important target for R&D this year for 48% of those surveyed was new product development, up from less than a third of respondents last year. For 30%, existing product improvement was the most important target. However, according to 63% of respondents, product […]
US President Barack Obama’s fiscal 2010 budget proposal includes a 0.4% increase in R&D spending over the fiscal 2009 enacted level to $147.6 billion. Funding for basic research would increase 3.4% to $30.9 billion, and spending for development would rise 0.2% to $84.1 billion. Funding for applied research would decline 2.2% to $28.1 billion. R&D […]
According to the World Steel Association, global steel demand will decrease 14.9% in 2009. This is in addition to the drop in output and profits currently plaguing the steel sector. In 1997, the last time demand for steel declined, demand fell 2.7%. The last double-digit decline was in 1945. Global steel production and consumption is […]
Medicare has proposed not to pay for tests to determine the proper dose of wafarin for a patient due to insufficient evidence of their effectiveness compared to current methods. The genetic tests costs $50–$500. However, Medicare stated it would pay for the tests in clinical trials. The public may comment on the proposal for one […]
The EPA plans to regulate greenhouse gases. Agency studies found that carbon dioxide, methane, nitrous oxide, hydrofluorocarbons, perfluorocarbons and sulfur hexafluoride are public health hazards. Source: New York Times
This year, the EPA will begin to implement the Endocrine Disruptor Screening Program (EDSP), which was established in 1998. Initially, 67 pesticide active ingredients and high-production volume chemicals used as pesticide inert ingredients will be screened. Tier 1 of the EDSP will screen the substances for interactions with estrogen, androgen or thyroid hormone systems. Substances […]
FoodProcessing.com estimates that capital spending by the top 20, publicly held, US food and beverage companies will decline 2.9% this year. Eleven of the 20 firms plan to increase capital spending in 2009. In some cases, the companies are planning to do so because of acquisitions, including Ralcorp and J.M. Smucker. Of the 11 companies […]
IMS Health forecasts the global pharmaceutical market to grow 2.5%–3.5% in 2009, excluding currency effects, to more than $750 billion. This is down from the previous estimate of 4.5%–5.5% growth (see IBO 10/31/08). Compound annual growth for 2009 through 2013 is estimated to be 3%–6%. IMS observed that consumers are less likely to start new […]
R&D spending by members of the Pharmaceutical Research and Manufacturers of America (PhRMA) increased 4.9% last year to an estimated $50,253.6 million. Domestic R&D spending rose 5.0% to $38,437.8 million and foreign R&D climbed 4.7% to $11,825.7 million. As a percentage of sales, R&D expenditures totaled 17.4%, compared to 17.5% in 2007. In 2007, PhRMA […]
A new report from the Centers for Disease Control and Prevention (CDC) indicates that US food safety has not improved since 2005. Sixteen of every 100,000 people had confirmed cases of salmonella in 2008, compared to 14 out of 100,000 in 2005. Although the increase may be a statistical anomaly, many foodborne illnesses, including listeria […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
